Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation

High expression of the Wilms' tumor gene (WT1) in acute myeloid leukemia (AML) has been considered as a sensitive marker of minimal residual disease (MRD). The present study investigated the significance of quantitative analysis of WT1 mRNA, combined with multiparameter flow cytometry (MFC) reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yingchan, Cheng, Yanhong, Wu, Quan, Zhang, Aimei, Jiang, Xiaoxiao, Xu, Xiucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774438/
https://www.ncbi.nlm.nih.gov/pubmed/29434724
http://dx.doi.org/10.3892/etm.2017.5547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774438/
https://www.ncbi.nlm.nih.gov/pubmed/29434724
http://dx.doi.org/10.3892/etm.2017.5547

Ejemplares similares